MIRA PHARMACEUTICALS INC (MIRA)

US60458C1045 - Common Stock

1.26  0 (0%)

After market: 1.2205 -0.04 (-3.13%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
N/AN/AN/A
EBITDA
YoY % growth
N/AN/AN/AN/AN/AN/A
-9.81%		N/A
6,240.78%
EBIT
YoY % growth
-67.63K-2.152M
-3,082.26%		-7.048M
-227.48%		-8.526M
-20.97%		N/A
3.61%		N/A
-9.83%		N/A
6,225.87%
Operating Margin
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/A
17.65%		N/A
12.50%		N/A
-10.20%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.17
26.09%		-0.14
-19.00%		-0.10
7.27%		-0.13
5.29%		-0.13
26.47%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/A-2.754M
-55.75%		-2.754M
-59.12%		N/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.14
46.15%		-0.160.0211.45%
Q2 2024
Q2Q % growth		 -0.11 -0.10-0.01-7.84%
Q1 2024
Q2Q % growth		 -0.12 -0.10-0.02-17.65%
Q3 2023
Q2Q % growth		 -0.26 -0.08-0.18-218.63%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -13.33% 0% -3.7%
RevenueN/A N/A N/A N/A